MedPath

Efficiency of azelastine hydrochloride and fluticasone propionate nasal spray to improve PAP adherence in patients with obstructive sleep apnea

Phase 4
Completed
Conditions
PAP adherence in patients with obstructive sleep apnea
Obstructive sleep apnea, PAP adherence, Intranasal corticosteroid, Continuous Positive Airway Pressure
Registration Number
TCTR20220308003
Lead Sponsor
Thammasat University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
116
Inclusion Criteria

1. First time diagnosis of Obstrutive sleep apnea in Thammasat university hospital
2. Age beween 18 to 75 year
3. Willingness to volunteer to participate in the trial and sign yhe informed consent form

Exclusion Criteria

1. use of any intranasal corticosteroids during the last 3 months
2. any serious impair cognitive function or dementia or psychological disorder likely to preclude completion of the trial
3. any disease that have indication to use Intranasal corticosteroid
4. any other sleep disorder eg. Narcolepsy, Insomnia, Parasomnia, Central sleep apnea

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.